Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
59,500
+100 (0.17%)
At close: Apr 30, 2026

Next Biomedical Revenue

In the year 2025, Next Biomedical had annual revenue of 16.48B KRW with 72.67% growth. Next Biomedical had revenue of 3.80B in the quarter ending December 31, 2025, with 70.60% growth.

Revenue
16.48B
Revenue Growth
+72.67%
P/S Ratio
29.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
488.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202516.48B6.93B72.67%
Dec 31, 20249.54B4.66B95.46%
Dec 31, 20234.88B2.09B74.67%
Dec 31, 20222.80B527.74M23.28%
Dec 31, 20212.27B6.63M0.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MEDIANA Co.,Ltd64.94B
JPI Healthcare48.47B
L&K Biomed38.92B
ASTERASYS Co.,Ltd37.94B
Hironic32.09B
SELVAS Healthcare30.82B
Remed24.50B
Neofect16.05B
Revenue Rankings